eldecalcitol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
- The Journal of endocrinology
- 2016
Postmenopausal women have high incidence of cardiovascular events as estrogen deficiency can cause endothelial dysfunction… (More)
Is this relevant?
Review
2014
Review
2014
- BoneKEy reports
- 2014
Eldecalcitol [1α,25-dihydroxy-2β-(3-hydroxypropyloxy)vitamin D3] is an analog of 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3], bearing… (More)
Is this relevant?
Review
2013
Review
2013
- The Journal of Steroid Biochemistry and Molecular…
- 2013
Vitamin D is known as a potent stimulator of bone resorption. The active form of vitamin D3, calcitriol (1α,25-dihydroxyvitamin… (More)
Is this relevant?
2012
2012
- Bone
- 2012
Eldecalcitol (ED-71), a 2β-hydroxypropyloxy derivative of 1α,25(OH)(2)D(3), inhibits bone resorption more potently than does… (More)
Is this relevant?
2012
2012
- Journal of bone and mineral research : the…
- 2012
Eldecalcitol (ED-71) is a new vitamin D₃ derivative recently approved for the treatment of osteoporosis in Japan. Previous… (More)
Is this relevant?
2011
2011
- Bone
- 2011
BACKGROUND
Eldecalcitol is an analog of 1,25-dihydroxyvitamin D(3) that improves bone mineral density; however, the effect of… (More)
Is this relevant?
2011
2011
- Bone
- 2011
To elucidate the histological events that follow administration of eldecalcitol, a second-generation of vitamin D analog… (More)
Is this relevant?
2011
2011
- Bone
- 2011
The effects of an active vitamin D analog, eldecalcitol (ELD), on bone mineral density (BMD), bone geometry, and biomechanical… (More)
Is this relevant?
2011
2011
- Calcified Tissue International
- 2011
The vitamin D analog 1α,25-dihydroxy-2β-(3-hydroxypropyloxy)vitamin D3 (ED-71 or eldecalcitol) has been developed for treatment… (More)
Is this relevant?
2010
2010
- The Journal of Steroid Biochemistry and Molecular…
- 2010
Eldecalcitol [ED-71, 2beta-(3-hydroxypropyloxy)-1,25-dihydroxyvitamin D3] increases lumbar and hip bone mineral density (BMD) in… (More)
Is this relevant?